Thursday - November 12, 2026
Goodwin Guides Prime Medicine on Pricing of $125 Million Public Offering
November 11, 2026
BOSTON, Massachusetts, Nov. 11 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Guides Prime Medicine on Pricing of $125 Million Public Offering

*

The Life Sciences team advised Prime Medicine, Inc. ("Prime") on its underwritten public offering of 35,714,286 shares of common stock at a public offering price of $3.50 per share. The aggregate gross proceeds to Prime from this offering are . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products